News

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
GlobalData on MSN8h
Can pharma tariffs “Make America Manufacture Again”?
Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
Donald Trump urged to target ‘lazy patent expansion’ in US drug bill push
Generics maker Sandoz says president should focus on tactic of ‘evergreening’ pricier products in his drive to lower costs ...
STAT1d
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's ...
Top 10 most expensive prescription drugs in the US by price and by sales volume
Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some ...
WIBC 93.1 FM8dOpinion
Trump Is The Most Successful Democrat Ever
LISTEN: Price caps lead to shortages. Want to reduce costs? Allow drug companies to sell directly and eliminate the middlemen ...
CEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing ...
Becker's Hospital Review1d
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
The American Hospital Association is raising alarms over the potential fallout from a series of recently implemented tariffs, warning it could negatively impact patient care and worsen existing drug ...